Half Year Results 

Mediclinic maintains full-year outlook

Mediclinic maintains full-year outlook

Mediclinic International (MDC) reported revenue growth for all three of its divisions during the six months to September 2019, driving an overall top-line improvement of 6 per cent at constant currencies. Adjusted cash profit margins landed in line with expectations across the board, and the private healthcare group returned to profit on a reported basis – helped by the fact that it did not endure the same £164m impairment charge that it took a year earlier, pertaining to its stake in Spire Healthcare (SPI). 

To continue reading, subscribe today

and enjoy unlimited access to the following:

  • Tips of the Week
  • Funds coverage
  • Weekly features on big investment themes
  • Trading ideas
  • Comprehensive companies coverage
  • Economic analysis
Subscribe
Subscribe to Investors Chronicle

Subscribe today

Full access for just £3.37 a week:

• Tips and recommendations - to beat the market 
• Portfolio clinic & Mr Bearbull - build a well-planned portfolio 
• Expert tools - track and manage investments effortlessly
• Plus free delivery to your home or office

Subscribe Now